Patents by Inventor Frederick K. Goodwin

Frederick K. Goodwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5248667
    Abstract: Peptides previously disclosed as useful for preventing HIV from binding to cell binding sites have now been shown to have thymoleptic qualities and to be useful for tretment of psoriasis in patients who lack antibodies against HIV.
    Type: Grant
    Filed: July 18, 1991
    Date of Patent: September 28, 1993
    Assignee: The United States of America as represented by the Secretary of the Department of Health & Human Services
    Inventors: Peter Bridge, Frederick K. Goodwin
  • Patent number: 5189022
    Abstract: The present invention relates to a method of treating chronic fatigue syndrome not associated with an HIV infection. In the method of the present invention patients are administered a pharmaceutically acceptable carrier together with(1) a neuropsychiatrically effective amount of a linear peptide of formula (I):R.sup.a -Ser-Thr-Thr-Thr-Asn-Tyr-R.sup.6 (I)whereinR.sup.a is Ala, D-Ala or Cys-Ala-, andR.sup.6 is Thr, Thr-amide, Thr-Cys or Thr-Cys-amide,or a derivative of the peptide or a physiologically acceptable salt thereof; or(2) a neuropsychiatrically effective amount of a linear peptide of formula (II):R.sup.1 -R.sup.2 -R.sup.3 -R.sup.4 -R.sup.5 (II)whereinR.sup.1 is X-Y or Y when Y is Thr-, Ser-, Asn-, Leu-, Ile-, Arg- or Glu-, and X is Cys;R.sup.2 is Thr-, Ser- or Asp;R.sup.3 is Thr, Ser, Asn, Arg, Gln, Lys or Trp;R.sup.4 is Tyr; andR.sup.
    Type: Grant
    Filed: May 8, 1991
    Date of Patent: February 23, 1993
    Assignee: The United States of America as represented by the Secretary of Health and Human Services
    Inventors: Thomas P. Bridge, Frederick K. Goodwin
  • Patent number: 5063206
    Abstract: The present invention relates to methods of treating mental disorders and memory deficits not caused by HIV infection. The methods involve administration of a thymoleptic effective amount of defined linear peptides to patients. The peptides can be administered for example, as a powder or a solution obtained by dissolving a powder in a pharmaceutically acceptable solvent.
    Type: Grant
    Filed: May 16, 1989
    Date of Patent: November 5, 1991
    Assignee: The United States of Americas as represented by the Department of Health and Human Services
    Inventors: Peter Bridge, Frederick K. Goodwin